RxDoctor Payments Data

Angela Hampton, PA

Physician Assistant · Bamberg, SCNPI 1568586790

Payments from drug & device makers

$909in general payments, 2019–2025

Across 43 payments — averaging $21.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$207
  • Novo Nordisk$142
  • AstraZeneca$85
  • Lilly USA, LLC$74
  • Takeda Pharmaceuticals U.S.A., Inc.$68
  • Bayer$55
  • plus $277 from 10 others

What the payments were for

  • Food & beverage$909100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$909 in reported general payments places this provider in the 65th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Medicare billing

Part B allowed, 2024
$5,648
Medicare patients
70
Services billed
137

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin131$119,061
OzempicSemaglutide65$96,850
JanuviaSitagliptin Phosphate82$88,031
FarxigaDapagliflozin Propanediol73$73,731
TrulicityDulaglutide69$72,994
EliquisApixaban98$70,475
LinzessLinaclotide68$60,904
KerendiaFinerenone44$40,893
Janumet XrSitagliptin Phos/Metformin Hcl47$34,586
JanumetSitagliptin Phos/Metformin Hcl31$30,424
XareltoRivaroxaban26$25,118
MyrbetriqMirabegron46$23,362
TradjentaLinagliptin15$18,940
MounjaroTirzepatide18$18,803
Breo ElliptaFluticasone/Vilanterol35$17,201

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$15$138,001146 claims
Novo NordiskOzempic$142$96,85065 claims
Lilly USA, LLCTrulicity, Mounjaro$74$91,79787 claims
AstraZenecaFarxiga, Symbicort$85$79,99399 claims
PfizerEliquis$17$70,47598 claims
AbbVieLinzess$207$60,90468 claims
BayerKerendia$55$40,89344 claims
Johnson & JohnsonXarelto$23$25,11826 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in Bamberg

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →